Carola Missaglia

BTK inhibitors synergise with 5‐FU to treat drug‐resistant TP53‐null colon cancers

K. Helin, V. Canzonieri, M. Agostini, 2020, The Journal of pathology.

GSK3A Is Redundant with GSK3B in Modulating Drug Resistance and Chemotherapy-Induced Necroptosis

M. Cerrito, E. Grassilli, M. Lavitrano, 2014, PloS one.

A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation

S. Bonin, K. Helin, M. Cerrito, 2015, Oncogene.